boston scientific news - Search News

Boston Scientific Corp. stock outperforms competitors

MarketWatch · 1d

Boston Scientific Corp. stock underperforms Tuesday when compared to competitors

Boston Scientific Corp. closed $1.60 below its 52-week high ($84.12), which the company achieved on September 13th.

Boston Scientific Corporation (BSX) Stock: Beyond the Surface of Its Performance?

Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $82.52 which represents a decrease of $-0.99 or -1.19% from the prior close of $83.51. The stock opened at $83.33 and touched a low of $81.

Pick Boston Scientific Stock After 130% Gains?

Investors have rewarded BSX stock thanks to the uptick in its sales for its new products and the Watchman line.

MarketWatch · 2d

Boston Scientific Corp. stock underperforms Monday when compared to competitors despite daily gains

Boston Scientific Corp. closed $0.61 short of its 52-week high ($84.12), which the company reached on September 13th.

What's Behind The 2x Rise In Boston Scientific Stock?

We estimate Boston Scientific’s Valuation to be $83 per share, aligning with its current levels of $82. At its current levels, BSX stock is trading at 8.2x revenues. The 8.2x figure is higher than the stock’s average P/S ratio of 5.

Boston Scientific closes $1.2B acquisition of California stroke prevention device maker

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of California medical ...

FDA approves expanded label for Boston Scientific Ingevity+ pacing leads

Boston Scientific (NYSE: BSX) received FDA approval to expand the indication for its current-generation Ingevity+ pacing ...

16h

Boston Scientific (BSX) Gets a Buy from Wells Fargo

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Boston Scientific (BSX – Research Report), ...

5d

Boston Scientific, Silk Road expect to close merger in ‘coming days’

Silk Road Medical said in a securities filing that the antitrust waiting period expired Thursday evening, opening the door to ...

Boston Scientific closes Silk Road Medical acquisition

Boston Scientific (NYSE: BSX) announced today that it completed its $1.16 billion acquisition of Silk Road Medical ...

18h

Boston Scientific’s Buy Rating: TAVR Developments Signal Market Growth and Revenue Potential

Bank of America Securities analyst Travis Steed has maintained their bullish stance on BSX stock, giving a Buy rating on September 5. Travis ...

5don MSN

Silk Road Medical ticks higher as HSR waiting period for Boston Scientific sale expires

Silk Road Medical (NASDAQ:SILK) edged higher by 0.7% in premarket trading after the HSR waiting period for its planned sale ...

GlobalData on MSN1d

Boston Scientific expands FDA label for Ingevity+ pacing leads

The expanded indication includes conduction system pacing (CSP) and sensing of the left bundle branch area (LBBA) for use ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results